Supply and Delivery of Erythropoiesis Stimulating Agents (ESAs)

A Modification Notice
by BUSINESS SERVICES ORGANISATION PROCUREMENT AND LOGISTICS SERVICE

Source: OJEU
Type: Contract (Supply)
Duration: 5 year
Value: £8M-£9M

Sector: HEALTH
Published: 05 Mar 2021
Delivery: To 05 Mar 2026 (est.)
Deadline: n/a

Concepts

Location

Belfast

Geochart for 2 buyers and 3 suppliers

2 buyers

Business Services Organisation Procurement & Logistics Service Belfast

3 suppliers

Amgen Cambridge
Janssen Cilag High Wycombe
Roche Products Welwyn Garden City Postal

Description

Contract was concluded for supply and delivery of a range of Erythropoiesis Stimulating Agents (ESAs).

Ammendments to Previous Notice

2. Contract value

GBP 1,500,000 9,000,000

Award Detail

1	Amgen (Cambridge) Supply and Delivery of a range of Erythropoiesis Stimulating Agents (ESAs) Reference: 17275 Value: £7,500,000 [share] Awarded to group of suppliers.
2	Janssen Cilag (High Wycombe) Supply and Delivery of a range of Erythropoiesis Stimulating Agents (ESAs) Reference: 17275 Value: £7,500,000 [share] Awarded to group of suppliers.
3	Roche Products (Welwyn Garden City Postal) Supply and Delivery of a range of Erythropoiesis Stimulating Agents (ESAs) Reference: 17275 Value: £7,500,000 [share] Awarded to group of suppliers.

CPV Codes

33600000 - Pharmaceutical products

Indicators

Contract modified due to unforeseen circumstances.

Legal Justification

The need for a further contract extension has been brought about by the circumstances of Covid-19 which have meant resources in the contracting authority have been redirected to efforts to support front line health and social care activities, including direct care for patients and efforts to support supply chain activities. As a result, scheduled re-tendering activity is being delayed while the current circumstances are present.

Reference

OJEU 114378-2021